×
Time:2024-01-13
Recently, NHU has secured approval for domestic drug registration of its API Coenzyme Q10, positioning the company as the first enterprise to receive such approval since the issuance of the National Medical Products Administration (NMPA)'s Announcement on Matters Related to Further Improving the Review, Approval, and Supervision of Drugs in 2019. This significant milestone indicates that our Coenzyme Q10 is at the forefront of the industry and paves the way for a new API market, presenting fresh opportunities for our development.
About Coenzyme Q10
Coenzyme Q10, a fat-soluble antioxidant, plays a crucial role in fortifying the myocardium, preventing heart aging, preventing and combating cancer, maintaining cardiovascular health, and enhancing overall vitality. The significant market demand for Coenzyme Q10 exists both domestically and internationally. The production of API Coenzyme Q10 necessitates stringent quality control and safety inspections, leading to rigorous requirements for production processes and product quality. NHU stands out as the inaugural company to receive such approval and recognition, demonstrating the company’s capability to produce high-quality API Coenzyme Q10 since the drug approval reform by the NMPA in 2019.
In its role as a guardian of nutrition and health, NHU is committed to the journey of open innovation. Starting from addressing future and potential market needs, we collaborate with academia and industry to delve into the cutting edges of chemical and biological science and technology and foster innovation and advancement, leading to the successful development of products like the Vitamin Series, Moxifloxacin Hydrochloride, and Taurine. NHU aims to create value for the entire industry and society, establishing a "Safety Moat" for human health.
On May 27, the launch ceremony of Shaoxing's 2026 Love Enterprise Action campaign was grandly held under the theme of Supporting Enterprises with Care, Empowering the Future with Intelligence. At the event, NHU was proud to receive three distinguished awards: Top 100 Private Enterprises in Shaoxing 2026, Top 10 Enterprises by R&D Investment in Shaoxing 2026, and Top 10 Foreign Trade Exporters in Shaoxing 2026. Ms. Zhang Liying, Vice President of the Company, attended the ceremony and accepted the awards on behalf of NHU. These recognitions reflect the strong endorsement of NHU’s overall strength, innovation capabilities, and global competitiveness by the Shaoxing Municipal Party Committee, the Municipal Government, and the wider community. They also underscore NHU’s role as a benchmark enterprise and a key contributor to regional economic development.
View details
In 2026, NHU's synthetic anethole officially received approval as a new food additive variety in China. NHU became the first company in the country to obtain food-grade certification for this product, filling a critical gap in domestic food-grade certification for synthetic anethole.
View details
On May 10, a delegation of over 30 leaders and experts from Sinopec, led by Wang Jiming (Member of the CAE and former President of Sinopec Corp.) and Nie Hong (Member of the CAE, former Deputy Director of the Sinopec Research Institute of Petroleum Processing and Chief Expert of Sinopec Group), visited NHU. Chairman Hu Baifan, Vice Chairman and President Hu Baifan, and Honorary Dean of the Research Institute Li Haoran warmly received the delegation. The two sides engaged in in-depth discussions on industrial development and potential areas of cooperation, reaching broad consensus.
View details